Document is current

Article History

Received: 17 November 2024

Accepted: 15 January 2025

First Online: 14 February 2025

Declarations

:

: The Colcheckpoint and BIONIKK cohorts have been approved by the French Health authorities and ethics committee [CPP Ile-de-France 8 (ref.16.10.69) and CPP Ouest I SI CNRIPH n18.11.21.67518 respectively]. All the participants provided written informed consent. Animal experiments were approved by the Ethics Committee of the University Paris Cité (CEEA34).

: Not applicable.

: V.V. has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events and support for attending meetings and/or travel from MSD. Y.V. has received consulting fees from BMS, Ipsen, Eisai, MSD, Pfizer; research grants from BMS, Ipsen. S.O. has received consulting fees, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events and support for attending meetings and/or travel from Pfizer, Novartis, Ipsen, Eisai, BMS, Merck; has participated in data safety monitoring board or advisory board from Roche, Ipsen, Eisai. The remaining authors declare that they have no competing interests.